Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (541-550 of 1,050) with videos related to

Pageof 105
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
Individual subsets of alternatively-activated macrophages differentially contribute to tissue repair and the resolution of inflammationKatharina Weishaupt, Jochen Ackermann, Philipp Burger, et al.
Annals of the Rheumatic Diseases|April 24, 2012
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosisBritta Maurer, Nicole Reich, Astrid Juengel, et al.
The New England Journal of Medicine|September 17, 2025
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus ErythematosusQian Wang, Ze Xiu Xiao, Xu Zheng, et al.
The Journal of Rheumatology|August 17, 2019
T2 Mapping as a New Method for Quantitative Assessment of Cartilage Damage in Rheumatoid ArthritisNina Renner, Arnd Kleyer, Gerhard Krönke, et al.
Arthritis Research & Therapy|June 9, 2018
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 studyIain B McInnes, Philip J Mease, Georg Schett, et al.
Scientific Reports|April 3, 2023
DeepNAPSI multi-reader nail psoriasis prediction using deep learningLukas Folle, Pauline Fenzl, Filippo Fagni, et al.
Cell Death and Differentiation|February 16, 2018
EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiationMarkus Linder, Manfred Hecking, Elisabeth Glitzner, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Synovial immunopathology in haemochromatosis arthropathyGisela Ruiz Heiland, Elmar Aigner, Tomás Dallos, et al.
Arthritis Research & Therapy|December 17, 2009
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesMarina Stolina, Georg Schett, Denise Dwyer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 2, 2026
AnnexinA1-Dectin 1 axis is a key regulator of osteoclastogenesis underlying irradiation induced bone loss in male miceGulnaz Guliyeva, Flora Nguemedjio Foko Takile, Verena Stallfort, et al.
Pageof 105

Showing results (541-550 of 1,050) with videos related to

Sort By:
Pageof 105
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
Individual subsets of alternatively-activated macrophages differentially contribute to tissue repair and the resolution of inflammationKatharina Weishaupt, Jochen Ackermann, Philipp Burger, et al.
Annals of the Rheumatic Diseases|April 24, 2012
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosisBritta Maurer, Nicole Reich, Astrid Juengel, et al.
The New England Journal of Medicine|September 17, 2025
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus ErythematosusQian Wang, Ze Xiu Xiao, Xu Zheng, et al.
The Journal of Rheumatology|August 17, 2019
T2 Mapping as a New Method for Quantitative Assessment of Cartilage Damage in Rheumatoid ArthritisNina Renner, Arnd Kleyer, Gerhard Krönke, et al.
Arthritis Research & Therapy|June 9, 2018
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 studyIain B McInnes, Philip J Mease, Georg Schett, et al.
Scientific Reports|April 3, 2023
DeepNAPSI multi-reader nail psoriasis prediction using deep learningLukas Folle, Pauline Fenzl, Filippo Fagni, et al.
Cell Death and Differentiation|February 16, 2018
EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiationMarkus Linder, Manfred Hecking, Elisabeth Glitzner, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Synovial immunopathology in haemochromatosis arthropathyGisela Ruiz Heiland, Elmar Aigner, Tomás Dallos, et al.
Arthritis Research & Therapy|December 17, 2009
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesMarina Stolina, Georg Schett, Denise Dwyer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 2, 2026
AnnexinA1-Dectin 1 axis is a key regulator of osteoclastogenesis underlying irradiation induced bone loss in male miceGulnaz Guliyeva, Flora Nguemedjio Foko Takile, Verena Stallfort, et al.
Pageof 105